Your browser doesn't support javascript.
loading
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
Rudick, R A; Goodkin, D E; Jacobs, L D; Cookfair, D L; Herndon, R M; Richert, J R; Salazar, A M; Fischer, J S; Granger, C V; Simon, J H; Alam, J J; Simonian, N A; Campion, M K; Bartoszak, D M; Bourdette, D N; Braiman, J; Brownscheidle, C M; Coats, M E; Cohan, S L; Dougherty, D S; Kinkel, R P; Mass, M K; Munschauer, F E; Priore, R L; Whitham, R H.
Affiliation
  • Rudick RA; Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44195-5244, USA.
Neurology ; 49(2): 358-63, 1997 Aug.
Article in En | MEDLINE | ID: mdl-9270562
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Interferon-beta / Disabled Persons / Multiple Sclerosis / Nervous System Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Neurology Year: 1997 Document type: Article Affiliation country: Country of publication:
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Interferon-beta / Disabled Persons / Multiple Sclerosis / Nervous System Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Neurology Year: 1997 Document type: Article Affiliation country: Country of publication: